Tacrograf 0.5 Tacrolimus Lorlatinib
MajorLorlatinib can lower the level of tacrolimus in the blood. Because tacrolimus has a narrow therapeutic index, meaning a small change in level matters, taking the two together should be avoided, since lorlatinib may reduce how much tacrolimus stays in the body. The same caution applies to other CYP3A4/5 substrates with narrow therapeutic indices, such as alfentanil, ciclosporin, dihydroergotamine, ergotamine, fentanyl, hormonal contraceptives, pimozide, quinidine and sirolimus.
These medicines can affect each other in a serious way. Do not start taking them together unless your doctor has said it is OK. If you already take both, do not stop either one on your own: speak to your doctor or pharmacist soon.